Ophthalmology Marketing Compliance: LASIK, Cataract Surgery, and Premium Lens Implants

Ophthalmology practices span refractive surgery (LASIK, PRK, SMILE, ICL), cataract surgery with premium lens options, medical ophthalmology, retina, glaucoma, oculoplastic, and pediatric ophthalmology. Each subcategory carries specific marketing compliance considerations. This post covers the full ophthalmology marketing framework.

LASIK and refractive surgery marketing

LASIK is one of the highest-volume elective surgery categories and a sustained FTC focus area.

• Outcome claims (20/20 vision, specific success rates) need substantiation.
• Bait pricing (“LASIK from $X”) with actual pricing substantially higher has drawn state AG attention.
• Comparison claims between LASIK, PRK, SMILE, and ICL need substantiation for specific comparisons made.
• Candidacy claims (“everyone is a candidate”) conflict with LASIK’s specific candidacy criteria.

Cataract and premium lens marketing

Cataract surgery with premium IOLs (multifocal, extended-depth-of-focus, toric) has specific compliance considerations:

• Premium lens marketing typically involves out-of-pocket charges beyond insurance coverage; pricing should be clear.
• Specific outcome claims (glasses-free vision, specific visual outcomes) need substantiation.
• Side effect disclosure (halos, glare, contrast sensitivity) matters for appropriate patient expectations.
• Comparison between premium lens brands requires substantiation.

Medical ophthalmology

Glaucoma, macular degeneration, diabetic retinopathy, and other medical conditions:

• Disease-specific outcome claims need careful substantiation.
• Scare-based marketing for conditions like glaucoma has drawn FTC attention.
• Specific treatment outcome percentages need published literature support.

Oculoplastic marketing

Cosmetic and reconstructive oculoplastic services (blepharoplasty, brow lift, injectables around the eye):

• Cosmetic oculoplastic follows aesthetic marketing framework.
• Medical oculoplastic (ptosis, ectropion, lacrimal) follows medical marketing framework.
• Before/after imagery rules apply particularly rigorously for periocular procedures where outcomes are highly visible.

Dry eye and medical device marketing

Ophthalmology practices increasingly offer dry eye devices (IPL, thermal pulsation, amniotic membrane). Compliance considerations mirror optometry dry eye marketing: FDA cleared indications, specific outcome substantiation, appropriate candidacy framing.

Board certification and credentialing

Ophthalmology is an ABMS-recognized specialty. Subspecialties (retina, cornea, glaucoma, oculoplastic, pediatric) have their own fellowship training. Marketing should accurately represent board certification and subspecialty training.

Compliant ophthalmology marketing framework

• Candidacy-forward refractive surgery marketing.Consultation as the entry point for determining candidacy.
• Premium lens pricing transparency.Clear disclosure of what insurance covers and what’s out-of-pocket.
• Outcome framing that matches evidence.“Most patients achieve [specific outcome]” with appropriate individual-variation language.
• Side-effect disclosure. Particularly for premium lens and refractive surgery.
• Accurate specialty and subspecialty credentialing.Specific fellowships and board certifications with sourcing.

Frequently asked questions

Can I guarantee 20/20 vision after LASIK?

No. LASIK outcomes vary by candidacy and individual healing. Specific outcome guarantees are unsubstantiable and create private-action exposure.

What about “LASIK from $X” pricing?

Must be accurate. If most patients don’t qualify for the advertised price, marketing should disclose what typical pricing looks like.

How do I handle premium lens marketing?

With clear pricing disclosure (insurance covers basic monofocal; premium lenses are additional cost) and realistic outcome framing including side effect potential.

Can I compare my LASIK technology to competitors?

Head-to-head comparison claims need substantiation. “Latest technology” without specific basis is a superlative concern.

What about Inspire-like retina treatments?

Retina treatments (anti-VEGF injections, specific surgical approaches) have specific FDA-approved indications. Marketing should reflect approved indications and accurate substantiation.

What documentation should ophthalmology practices maintain?

Practice-specific outcome data if used in marketing, device FDA documentation, board certification documentation, substantiation for specific claims, pricing-disclosure records.